Redsenol
 | This article needs more medical references for verification or relies too heavily on primary sources. (May 2025) |  |
| Lua error in Module:WikidataIB at line 665: attempt to index field 'wikibase' (a nil value). | |
| Type | lua error in module:wikidataib at line 665: attempt to index field 'wikibase' (a nil value). |
|---|---|
| Inventor | Lua error in Module:WikidataIB at line 665: attempt to index field 'wikibase' (a nil value). |
| Inception | Lua error in Module:WikidataIB at line 665: attempt to index field 'wikibase' (a nil value). |
| Manufacturer | Lua error in Module:WikidataIB at line 665: attempt to index field 'wikibase' (a nil value). |
| Available | Yes |
| Website | Lua error in Module:WikidataIB at line 665: attempt to index field 'wikibase' (a nil value). |
Search Redsenol on Amazon.
Redsenol is a ginsenoside supplement which is developed by Canada Royal Enoch Phytomedicine, a pharmaceutical company headquartered in British Columbia, Canada that researches and develops ginsenosides.[1][2][3][4]
In 2018, Redsenol Ginsenosides was certified by the Banned Substances Control Group (BSCG) under its BSCG Certified Drug Free® program.[5]
In March 2025, Redsenol-1 Plus Noble Ginsenosides has been included in the National Cancer Institute's (NCI) Drug Dictionary.[2][1][6][7]
Currently, Redsenol-1 Plus is undergoing a clinical trial to evaluate its efficacy in reducing cancer-related fatigue, which began in 2022.[8]
See also
Notes
![[icon]](/File:Wiki_letter_w_cropped.svg){kind=small} | This section is empty. You can help by adding to it. (May 2025) |
References
- ↑ 1.0 1.1 "Ginsenoside Supplement Redsenol-1 Plus Gains Recognition in National Cancer Institute's Drug Dictionary". citybuzz. 2025-03-13.
- ↑ 2.0 2.1 "Ginsenoside Supplement Redsenol-1 Plus Included in National Cancer Institute's Drug Dictionary". finance.yahoo.com.
- ↑ Ltd, Canada Royal Enoch Phytomedicine. "Canada Royal Enoch Phytomedicine Launches Clinical Trial of its Ginseng-Derived Redsenol-1 Plus Noble Ginsenoside Capsules". www.prnewswire.com (Press release).
- ↑ "https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ginsenosides-supplement". www.cancer.gov. 2 February 2011. Retrieved 9 May 2025. External link in
|title=(help) - ↑ "Redsenol Takes a Big Step Forward Toward the Best Ginsenoside Brand". markets.financialcontent.com.
- ↑ Magazine, I. H. R. (17 March 2025). "Redsenol-1 Plus Listed in NCI Drug Dictionary". IHR Magazine.
- ↑ "Come For Health, fully experience good health by providing the finest supplements, foods, and lifestyle solution". ComeForHealth.
- ↑ "A Randomized, Triple-blind, Placebo Controlled, Parallel Clinical Trial to Investigate the Safety and Efficacy of Redsenol-1 Plus on Cancer-related Fatigue in Adults". clinicaltrials.gov. 3 April 2024.
This article "Redsenol" is from Wikipedia. The list of its authors can be seen in its historical and/or the page Edithistory:Redsenol. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.
